MYELODYSPLASIA
Clinical trials for MYELODYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stem cell transplant could help kids beat blood cancer with fewer side effects
Disease control OngoingThis study is for children with blood cancers or bone marrow disorders who need a stem cell transplant but don't have a perfectly matched donor. It tests a new method using a partially matched family donor, where certain immune cells are removed from the donated cells to help the…
Matched conditions: MYELODYSPLASIA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 17, 2026 03:29 UTC
-
Half-Matched stem cell transplant shows promise for blood cancer patients
Disease control OngoingThis study tested a stem cell transplant using blood stem cells from a half-matched (haploidentical) donor for people with blood cancers like leukemia and lymphoma. The goal was to see how many patients survived and had successful engraftment by 100 days and one year after transp…
Matched conditions: MYELODYSPLASIA
Phase: PHASE3 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated May 17, 2026 03:26 UTC
-
Cord blood boost: new stem cell therapy aims to speed recovery in blood cancer patients
Disease control OngoingThis study tests a new stem cell treatment called MGTA-456 for people with high-risk blood cancers like leukemia and lymphoma. The treatment uses a special process to grow more stem cells from donated umbilical cord blood before transplant. The goal is to help the body rebuild he…
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New stem cell method shows promise for tough blood cancers
Disease control OngoingThis study tests a stem cell transplant from unrelated or partially matched donors for people with blood cancers like leukemia, lymphoma, or myelodysplasia. The donated cells are specially treated to remove certain immune cells, which may help the transplant take hold and reduce …
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 12, 2026 13:42 UTC